Over the last 4 years, we have witnessed an increase amount of interests, as well as actual commercial projects, in commercializing continuous manufacturing.
Our annual meeting in Boston have seen a global community with audience from the US, EMEA and APAC to share their latest journeys and lessons learned with each other. While encouraging advancements have been made in this field, various challenges remain ahead of us: small molecules have proven early success and biologics will definitely follow suit with lucrative opportunities.
Demonstrating a valid business case, maintaining quality under continuous processing, gaining approval and adopting innovative real-time product release are the next phase of focus – in order to uphold drug product quality throughout transitioning.
The 4th CCP Summit will return to Boston as the only commercial pharmaceutical meeting dedicated to continuous processing, helping you accelerate the switch from batch to CM.
Our mission statement is to help the pharma and biotechs adopt and implement a fit-for-purpose continuous processing, which will ultimately deliver quality and cost-effective medicines to patients globally.
Since we launched in 2016, our community has expanded rapidly. Coming to the 4th year, we are excited to have:
- A complete fresh speaker line-up
- 2 parallel tracks to cater for small molecules and biologics expert
And many others…
Join our 130+ CM industry pioneers in 2020 to hear their lessons learned and actionable insights!